TMEM43 and Ventricular arrhythmia: Mutant TMEM43 was first described in families from Newfoundland (Canada) in 2008, as the cause of a fully penetrant aggressive disease with a high incidence of malignant ventricular arrhythmias, and was defined as ACM/ARVC type 5 [2].